- Home
- CGC vs TALKW Comparison
CGC vs TALKW Comparison
Compare CGC & TALKW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CGC
- TALKW
- Stock Information
- Founded
- CGC N/A
- TALKW 2012
- Country
- CGC Canada
- TALKW United States
- Employees
- CGC N/A
- TALKW 521
- Industry
- CGC Pharmaceuticals and Biotechnology
- TALKW Medical/Nursing Services
- Sector
- CGC Health Care
- TALKW Health Care
- Exchange
- CGC Nasdaq
- TALKW Nasdaq
- Market Cap
- CGC 244.5M
- TALKW N/A
- IPO Year
- CGC N/A
- TALKW N/A
- Fundamental
- Price
- CGC $1.23
- TALKW $0.07
- Analyst Decision
- CGC Sell
- TALKW
- Analyst Count
- CGC 2
- TALKW 0
- Target Price
- CGC $2.00
- TALKW N/A
- AVG Volume (30 Days)
- CGC 8.6M
- TALKW 64.2K
- Earning Date
- CGC 08-08-2025
- TALKW 02-20-2025
- Dividend Yield
- CGC N/A
- TALKW N/A
- EPS Growth
- CGC N/A
- TALKW N/A
- EPS
- CGC N/A
- TALKW N/A
- Revenue
- CGC $187,146,485.00
- TALKW $181,291,000.00
- Revenue This Year
- CGC $11.99
- TALKW N/A
- Revenue Next Year
- CGC $6.84
- TALKW N/A
- P/E Ratio
- CGC N/A
- TALKW N/A
- Revenue Growth
- CGC N/A
- TALKW 31.50
- 52 Week Low
- CGC $0.77
- TALKW $0.20
- 52 Week High
- CGC $8.65
- TALKW $0.24
- Technical
- Relative Strength Index (RSI)
- CGC 42.31
- TALKW N/A
- Support Level
- CGC $1.16
- TALKW N/A
- Resistance Level
- CGC $1.29
- TALKW N/A
- Average True Range (ATR)
- CGC 0.12
- TALKW 0.00
- MACD
- CGC -0.03
- TALKW 0.00
- Stochastic Oscillator
- CGC 12.50
- TALKW 0.00
About CGC Canopy Growth Corporation
Canopy Growth Corp, cultivates and sells medicinal and recreational cannabis and hemp through a portfolio of brands that include Doja, LivRelief, Ace Valley, Deep Space, and others. The Company is engaged in reportable segments namely: Canada cannabis, International markets cannabis, Storz & Bickel, and This Works. The company generates maximum revenue from Canadian cannabis.
About TALKW Talkspace Inc. Warrant
Talkspace Inc is a behavioral healthcare company offering access to licensed therapists, psychologists, and psychiatrists through its technology platform. It serves clients including health plans, enterprises, and individual subscribers. Therapists address various mental health conditions, while psychiatrists cater to a higher acuity demographic. Revenue stems from payor and direct-to-enterprise clients, with contracts lasting one to three years. The majority of the Company's operations and revenues are based in the United States.